Literature DB >> 22209664

Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis.

Shivam Champaneri1, Xiaoqiang Xu, Mercedes R Carnethon, Alain G Bertoni, Teresa Seeman, Ana Diez Roux, Sherita Hill Golden.   

Abstract

The objective was to examine the cross-sectional association of diurnal salivary cortisol curve components and urinary catecholamines with diabetes status. Up to 18 salivary cortisol samples over 3 days and overnight urinary catecholamines were collected from 1002 participants in the Multi-Ethnic Study of Atherosclerosis. Diabetes was defined as a fasting blood glucose of at least 126 mg/dL or medication use. Cortisol curve measures included awakening cortisol, cortisol awakening response, early decline, late decline, and cortisol area under the curve (AUC). Urinary catecholamines included epinephrine, norepinephrine, and dopamine. Participants with diabetes had significantly lower cortisol awakening response (β = -0.19; 95% confidence interval [CI], -0.34 to -0.04) than those without diabetes in multivariable models. Whereas men with diabetes had a nonsignificant trend toward lower total AUC (β = -1.56; 95% CI, -3.93 to 0.80), women with diabetes had significantly higher total AUC (β = 2.62; 95% CI, 0.72 to 4.51) (P = .02 for interaction) compared with those without diabetes. Men but not women with diabetes had significantly lower urinary catecholamines compared with those without diabetes (P < .05). Diabetes is associated with neuroendocrine dysregulation, which may differ by sex. Further studies are needed to determine the role of the neuroendocrine system in the pathophysiology of diabetes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209664      PMCID: PMC3319636          DOI: 10.1016/j.metabol.2011.11.006

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  49 in total

1.  Association between time of awakening and diurnal cortisol secretory activity.

Authors:  S Edwards; P Evans; F Hucklebridge; A Clow
Journal:  Psychoneuroendocrinology       Date:  2001-08       Impact factor: 4.905

2.  Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

Authors:  Iacopo Chiodini; Massimo Torlontano; Alfredo Scillitani; Maura Arosio; Simonetta Bacci; Sergio Di Lembo; Paolo Epaminonda; Giovanni Augello; Riccardo Enrini; Bruno Ambrosi; Guido Adda; Vincenzo Trischitta
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

3.  Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis.

Authors:  Anjum Hajat; Ana Diez-Roux; Tracy G Franklin; Teresa Seeman; Sandi Shrager; Nalini Ranjit; Cecilia Castro; Karol Watson; Brisa Sanchez; Clemens Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  2010-01-29       Impact factor: 4.905

4.  Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity.

Authors:  J C Pruessner; O T Wolf; D H Hellhammer; A Buske-Kirschbaum; K von Auer; S Jobst; F Kaspers; C Kirschbaum
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

5.  State and trait affect as predictors of salivary cortisol in healthy adults.

Authors:  Deborah E Polk; Sheldon Cohen; William J Doyle; David P Skoner; Clemens Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  2005-04       Impact factor: 4.905

6.  The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes.

Authors:  A F Godoy-Matos; A R Vieira; R O Moreira; W F Coutinho; L M Carraro; D M Moreira; R Pasquali; R M R Meirelles
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

7.  Plasma norepinephrine in sensory diabetic polyneuropathy.

Authors:  C Tsigos; P Reed; C Weinkove; A White; R J Young
Journal:  Diabetes Care       Date:  1993-05       Impact factor: 19.112

8.  Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma.

Authors:  T D Wiesner; M Blüher; M Windgassen; R Paschke
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

9.  Impaired catecholamine secretion as a cause of diabetic autonomic neuropathy.

Authors:  H Fushimi; T Inoue; Y Matsuyama; B Kishino; M Kameyama; S Funakawa; Y Tochino; A Yamatodani; H Wada; T Minami
Journal:  Diabetes Res Clin Pract       Date:  1988-04-06       Impact factor: 5.602

10.  Whites have a more robust hypothalamic-pituitary-adrenal axis response to a psychological stressor than blacks.

Authors:  Rachel Y Chong; Magdalena Uhart; Mary E McCaul; Elizabeth Johnson; Gary S Wand
Journal:  Psychoneuroendocrinology       Date:  2007-12-20       Impact factor: 4.905

View more
  35 in total

1.  The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.

Authors:  Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2018-12-27       Impact factor: 4.905

2.  Association of Sleep Duration and Quality With Alterations in the Hypothalamic-Pituitary Adrenocortical Axis: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Cecilia Castro-Diehl; Ana V Diez Roux; Susan Redline; Teresa Seeman; Sandi E Shrager; Steven Shea
Journal:  J Clin Endocrinol Metab       Date:  2015-06-05       Impact factor: 5.958

Review 3.  Type 2 diabetes and cardiovascular disease: what next?

Authors:  Joshua J Joseph; Sherita Hill Golden
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

4.  IN MY OWN WORDS: THE VALUE OF STORYTELLING TO SHAPE THE ACADEMIC MEDICINE JOURNEY.

Authors:  Sherita Hill Golden
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

5.  Antecedent longitudinal changes in body mass index are associated with diurnal cortisol curve features: The multi-ethnic study of atherosclerosis.

Authors:  Joshua J Joseph; Xu Wang; Ana V Diez Roux; Brisa N Sanchez; Teresa E Seeman; Belinda L Needham; Sherita Hill Golden
Journal:  Metabolism       Date:  2016-12-08       Impact factor: 8.694

6.  How stable are diurnal cortisol activity indices in healthy individuals? Evidence from three multi-wave studies.

Authors:  Kharah M Ross; Michael L M Murphy; Emma K Adam; Edith Chen; Gregory E Miller
Journal:  Psychoneuroendocrinology       Date:  2013-09-21       Impact factor: 4.905

7.  Job Strain and the Cortisol Diurnal Cycle in MESA: Accounting for Between- and Within-Day Variability.

Authors:  Kara E Rudolph; Brisa N Sánchez; Elizabeth A Stuart; Benjamin Greenberg; Kaori Fujishiro; Gary S Wand; Sandi Shrager; Teresa Seeman; Ana V Diez Roux; Sherita H Golden
Journal:  Am J Epidemiol       Date:  2016-02-22       Impact factor: 4.897

8.  Individual differences in glucocorticoid regulation: Does it relate to disease risk and resilience?

Authors:  Jasmine I Caulfield; Sonia A Cavigelli
Journal:  Front Neuroendocrinol       Date:  2019-11-04       Impact factor: 8.606

Review 9.  Biomarkers of Key Biological Pathways in CVD.

Authors:  Nancy Swords Jenny; Nels C Olson; Matthew A Allison; Dena E Rifkin; Lori B Daniels; Ian H de Boer; Christina L Wassel; Russell P Tracy
Journal:  Glob Heart       Date:  2016-09

Review 10.  Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.

Authors:  Joshua J Joseph; Sherita H Golden
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.